immune checkpoint antibody development The demand for antibodies with higher affinity and specificity is increasingly important for diagnostic and therapeutic applications in immune checkpoint therapy to eliminate nonspecific and off-target interactions. To design and synthesize the next-generation novel antibodies, a set of analytical methods is needed to characterize, screen, sort, select, and determine the binding kinetics of the antibodies against an array of antigens.
